SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-075528
Filing Date
2021-03-10
Accepted
2021-03-10 07:35:56
Documents
15
Period of Report
2021-03-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d108231d8k.htm   iXBRL 8-K 28362
2 EX-99.1 d108231dex991.htm EX-99.1 95152
7 GRAPHIC g108231g0309022842652.jpg GRAPHIC 4784
  Complete submission text file 0001193125-21-075528.txt   301196

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA xoma-20210310.xsd EX-101.SCH 4112
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE xoma-20210310_def.xml EX-101.DEF 13851
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE xoma-20210310_lab.xml EX-101.LAB 22846
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xoma-20210310_pre.xml EX-101.PRE 14820
8 EXTRACTED XBRL INSTANCE DOCUMENT d108231d8k_htm.xml XML 5432
Mailing Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608
Business Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608 510-204-7239
XOMA Corp (Filer) CIK: 0000791908 (see all company filings)

IRS No.: 522154066 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39801 | Film No.: 21728269
SIC: 2834 Pharmaceutical Preparations